Quarterly report pursuant to Section 13 or 15(d)

Organization and Nature of Business (Details Narrative)

v3.20.1
Organization and Nature of Business (Details Narrative) - USD ($)
3 Months Ended
Dec. 20, 2019
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]        
Cash   $ 1,000    
Working capital deficiency   14,000,000    
Net cash used in operating activities   (297,215) $ (528,233) [1]  
Accumulated deficit   (48,596,368)   $ (52,934,786)
Proceeds from debt and equity financing   286,500    
Reverse stock split 1,000-for-1-reverse stock split      
Provision for doubtful accounts   0   $ 0
Research and development expenses   $ 1,003 $ 63,301  
[1] The condensed consolidated financial statements have been retroactively restated to reflect the 1,000-for-1-reverse stock split that occurred in December 20, 2019.